Voloridge Investment Management, LLC Vericel Corp Transaction History

Voloridge Investment Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $1.93 Million - $2.77 Million	-85,102 Reduced 84.86%	15,181 $352,000
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $1.15 Million - $1.99 Million	50,477 Added 101.35%	100,283 $2.53 Million
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $2.14 Million - $2.92 Million	-67,543 Reduced 57.56%	49,806 $1.9 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $387,622 - $579,231	11,012 Added 10.36%	117,349 $4.61 Million
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $770,151 - $992,806	-16,616 Reduced 13.51%	106,337 $5.19 Million
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $822,271 - $1.18 Million	-17,421 Reduced 12.41%	122,953 $6.46 Million
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $1.2 Million - $2.31 Million	38,765 Added 38.15%	140,374 $7.8 Million
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $150,648 - $256,095	-8,130 Reduced 7.41%	101,609 $3.14 Million
Q3 2020 Nov 16, 2020	BUY	$14.68 - $19.12 $563,198 - $733,538	38,365 Added 53.75%	109,739 $2.03 Million
Q2 2020 Aug 14, 2020	BUY	$8.5 - $15.82 $606,679 - $1.13 Million	71,374 New	71,374 $986,000
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $340,119 - $901,667	-46,913 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $645,992 - $900,729	46,913 New	46,913 $816,000
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $264,551 - $332,936	-17,625 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $286,053 - $357,611	17,625 New	17,625 $309,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.